Why Epizyme Inc. Shares Rocketed Higher
Epizyme shares soar after the company reaches another creative milestone with partner GlaxoSmithKline.
What You Ought To Know About Celgene's Deal-Making Magic
Celgene's investment team has made a string of savvy investments in early stage biotech companies.
Stocks: Insiders Buy at Epizyme and Intergrated Device Technology
Plus, purchases at Genocea Biosciences and Gladstone Investment and a sale at Epizyme.